Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
57,960,273
-
Share change
-
+1,386,527
-
Total reported value
-
$934,914,487
-
Put/Call ratio
-
1800%
-
Price per share
-
$16.13
-
Number of holders
-
163
-
Value change
-
+$29,373,278
-
Number of buys
-
86
-
Number of sells
-
64
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q4 2023
As of 31 Dec 2023,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,960,273 shares.
The largest 10 holders included
BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ARMISTICE CAPITAL, LLC, Redmile Group, LLC, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Polar Capital Holdings Plc, and DIMENSIONAL FUND ADVISORS LP.
This page lists
163
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.